In this interview from Pittcon 2020 in Chicago, Prof. Livia Eberlin delves into the revolutionary role of mass spectrometry-based techniques in the diagnosis and treatment of cancer. From the inception of the MasSpec Pen, which allows surgeons to quickly assess tumor margins during surgery, to the broader impact of mass spectrometry in oncology, Eberlin's work stands as a testament to the fusion of analytical science and clinical medicine. Discover how her journey began and how her innovations are paving the way for more accurate and faster cancer treatments. For an in-depth exploration of her groundbreaking work, read the full interview here: www.news-medical.net/news/20200616/Accelerating-the-Diagnosis-and-Treatment-of-Cancer-with-Mass-Spectrometry-Based-Techniques.aspx

Be the first to comment